Maintaining social connection in a time of physical distance

  • May 27, 2020

The arrival of the novel coronavirus has raised unprecedented challenges across the globe. In our collective effort to help flatten the curve of this pandemic, we are making substantial changes to our daily lives. Physical distancing policies currently in place…

When the best prescription is deprescribing

  • January 29, 2020

Several years ago, an elderly patient — let’s call her Eve — came to Kaiser Permanente because she was dazed and feeling “out of it” on a regular basis. Her family chalked it up to old age and eventually contemplated…

Annie Reed

Building healthier school environments for students and employees

  • January 8, 2020

Schools are arguably one the most effective places to address population health, including the physical and mental health needs of students, teachers, and school staff. The school environment is an important area of focus, and one that can hold the…

Polly Webster

The promise — and challenges — of gene therapy

  • January 6, 2020

What good is a life-saving, ground-breaking treatment that patients and the health care system cannot access or afford? This question was front of mind for me during last fall’s Brocher Foundation meeting about cell and gene therapies: cutting-edge therapies that…

Rena Conti

Determining drug value: Let’s start with the evidence

  • October 24, 2019

Last month, I was pleased to speak at the Institute for Health Policy forum that delved into a critical topic in the drug pricing dialogue: drug value. When I arrived in Washington, D.C., I was struck by how far we’ve…